Babczyńska, Monika, et al. “Comparative Effectiveness of Risankizumab Vs Other Biologics in Crohn’s Disease: Long-Term and Quality-of-Life Outcomes After Inadequate Response to Prior Therapy”. Quality in Sport, vol. 41, May 2025, p. 59986, doi:10.12775/QS.2025.41.59986.